Tural, D. Et Al. 2024. Objective Response Rate is a Surrogate Marker for Long-Term Overall Survival in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors. Clinical Genitourinary Cancer , vol.22, no.5 .

Tural, D., Arslan, C., Selcukbiricik, F., ÖLMEZ, Ö. F., ERMAN, M., ÜRÜN, Y., ... Erdem, D.(2024). Objective Response Rate is a Surrogate Marker for Long-Term Overall Survival in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors. Clinical Genitourinary Cancer , vol.22, no.5.

Tural, Deniz Et Al. "Objective Response Rate is a Surrogate Marker for Long-Term Overall Survival in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors," Clinical Genitourinary Cancer , vol.22, no.5, 2024

Tural, Deniz Et Al. "Objective Response Rate is a Surrogate Marker for Long-Term Overall Survival in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors." Clinical Genitourinary Cancer , vol.22, no.5, 2024

Tural, D. Et Al. (2024) . "Objective Response Rate is a Surrogate Marker for Long-Term Overall Survival in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors." Clinical Genitourinary Cancer , vol.22, no.5.

@article{article, author={Deniz Tural Et Al. }, title={Objective Response Rate is a Surrogate Marker for Long-Term Overall Survival in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors}, journal={Clinical Genitourinary Cancer}, year=2024}